RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., Sept. 13, 2021 /PRNewswire-AsiaNet/ -- - The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care- Number of U.S. si...
Authors: LATEST ASIANET NEWS RELEASES